The Net Margin of Corline Biomedical AB (CLBIO.ST) is -237.28%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -237.28% |
| 2023-12-31 | -7.23% |
| 2022-12-31 | 9.89% |
| 2021-12-31 | -98.02% |
| 2020-12-31 | -197.16% |
| 2019-12-31 | -896.62% |
| 2018-12-31 | -434.61% |
| 2017-12-31 | -1224.14% |
| 2016-12-31 | -554.17% |
| 2015-12-31 | -563.62% |